Pipeline
We are advancing a differentiated and diverse pipeline of small molecule therapeutics that are precisely engineered to be either highly CNS-penetrant or peripherally restricted. Our candidates target three key drivers of disease by resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function.
Investors and Media
Stay current with Tenvie
Contact
Reach out to us